P&G's Wellness Gamble: A Story of Two Outcomes Procter & Gamble's latest deal has left investors with mixed feelings, as the company's acquisition of Thorne for $3.
8 billion adds a new chapter to its wellness story while casting a shadow over its near term prospects.
The purchase of Thorne, a science backed health and wellness brand with 40 years of clinical credibility behind it, marks a significant expansion into a category built on trust rather than shelf space.